Joseph, W.S.; Culshaw, D.; Anuskiewicz, S.; De Anda, C.; Prokocimer, P.
Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non–Lower-Extremity Infections. Pooled Analysis of Two Phase 3 Trials. J. Am. Podiatr. Med. Assoc. 2017, 107, 264-271.
https://doi.org/10.7547/15-218
AMA Style
Joseph WS, Culshaw D, Anuskiewicz S, De Anda C, Prokocimer P.
Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non–Lower-Extremity Infections. Pooled Analysis of Two Phase 3 Trials. Journal of the American Podiatric Medical Association. 2017; 107(4):264-271.
https://doi.org/10.7547/15-218
Chicago/Turabian Style
Joseph, Warren S., Darren Culshaw, Steven Anuskiewicz, Carisa De Anda, and Philippe Prokocimer.
2017. "Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non–Lower-Extremity Infections. Pooled Analysis of Two Phase 3 Trials" Journal of the American Podiatric Medical Association 107, no. 4: 264-271.
https://doi.org/10.7547/15-218
APA Style
Joseph, W. S., Culshaw, D., Anuskiewicz, S., De Anda, C., & Prokocimer, P.
(2017). Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non–Lower-Extremity Infections. Pooled Analysis of Two Phase 3 Trials. Journal of the American Podiatric Medical Association, 107(4), 264-271.
https://doi.org/10.7547/15-218
